Cargando…
IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer
BACKGROUND: Since the publication of MA-20 and EORTC-22922 trials, chest wall (CW)/ whole breast (WB) irradiation + comprehensive regional nodal irradiation (RNI) with internal mammary node irradiation (IMNI) has been the standard adjuvant treatment for early-stage breast cancer (BC). However, one s...
Autores principales: | Qi, Wei-Xiang, Cao, Lu, Zheng, Siyue, Xu, Cheng, Cai, Rong, Xu, Haoping, Cai, Gang, Chen, Jiayi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795778/ https://www.ncbi.nlm.nih.gov/pubmed/36575421 http://dx.doi.org/10.1186/s12885-022-10454-1 |
Ejemplares similares
-
Hypofractionated versus conventional intensity-modulated radiation irradiation (HARVEST-adjuvant): study protocol for a randomised non-inferior multicentre phase III trial
por: Xie, Jinrong, et al.
Publicado: (2022) -
The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro‐metastases
por: Houvenaeghel, Gilles, et al.
Publicado: (2022) -
Infiltration tendency of internal mammary lymph nodes involvement in patients with breast cancer: anatomical characteristics and implications for target delineation
por: Wang, Yujie, et al.
Publicado: (2019) -
Omission
Publicado: (1881) -
An Omission
Publicado: (1885)